| Name | Title | Contact Details |
|---|
Avivia Health From Kaiser Permanente is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Alliance Homecare is a private home healthcare company offering an extensive range of services, including Private Duty Nursing, Home Health Aides, and Geriatric Care Management. As a Licensed Home Care Services Agency (LHCSA), we cater to a sophisticated client base in the New York metropolitan area. We staff only the highest quality Registered Nurses, Home Health Aides, and healthcare professionals. These individuals understand that our clients expect the very best talent in home care. Our company is committed to providing world class care to our patients and their loved ones while honoring a strict code of confidentiality. We offer an elite and highly qualified team of healthcare professionals who uphold the strongest principles of integrity and professionalism. The company was founded in 2006 by Gregory Solometo and two childhood friends who are both Registered Nurses. Gregory wanted to take a different approach to home care after he discovered how difficult it was to find quality caregivers to look after his grandmother with Alzheimer`s. During her five-year journey with the disease, Gregory encountered firsthand the challenges and costs of caring for an elderly family member, both in the home and in a facility. Now, our dedicated and professional staff are here to help you and your family find the best home care available.
Questcare Management Svc Inc is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Gwc Technologies Inc is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.